Published in Mol Cell Proteomics on February 02, 2005
Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity. Nat Commun (2016) 2.22
Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells. Oncogene (2009) 1.69
Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer. Breast Cancer Res (2009) 1.37
Mage-b vaccine delivered by recombinant Listeria monocytogenes is highly effective against breast cancer metastases. Br J Cancer (2008) 1.29
Plasma membrane proteomics and its application in clinical cancer biomarker discovery. Mol Cell Proteomics (2010) 1.27
Visceral adiposity, insulin resistance and cancer risk. Diabetol Metab Syndr (2011) 1.26
Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon? EPMA J (2013) 1.17
Diverse and active roles for adipocytes during mammary gland growth and function. J Mammary Gland Biol Neoplasia (2010) 1.07
Quantitative analysis of breast parenchymal patterns using 3D fibroglandular tissues segmented based on MRI. Med Phys (2010) 1.05
Interstitial fluid: the overlooked component of the tumor microenvironment? Fibrogenesis Tissue Repair (2010) 1.02
Obesity and breast cancer: the roles of peroxisome proliferator-activated receptor-γ and plasminogen activator inhibitor-1. PPAR Res (2009) 1.01
Advances in the proteomic investigation of the cell secretome. Expert Rev Proteomics (2012) 1.00
An "elite hacker": breast tumors exploit the normal microenvironment program to instruct their progression and biological diversity. Cell Adh Migr (2012) 0.99
Nerve growth factor in cancer cell death and survival. Cancers (Basel) (2011) 0.96
In utero exposure to butyl benzyl phthalate induces modifications in the morphology and the gene expression profile of the mammary gland: an experimental study in rats. Environ Health (2011) 0.94
Oncoproteomic profiling with antibody microarrays. Genome Med (2009) 0.92
Characterization of the Human Adipocyte Proteome and Reproducibility of Protein Abundance by One-Dimensional Gel Electrophoresis and HPLC-ESI-MS/MS. J Proteome Res (2010) 0.92
Early vascular deficits are correlated with delayed mammary tumorigenesis in the MMTV-PyMT transgenic mouse following genetic ablation of the NG2 proteoglycan. Breast Cancer Res (2012) 0.89
Reproductive abnormalities in mice expressing omega-3 fatty acid desaturase in their mammary glands. Transgenic Res (2010) 0.87
Identification of candidate circulating cisplatin-resistant biomarkers from epithelial ovarian carcinoma cell secretomes. Br J Cancer (2013) 0.86
Cancer predisposition in diabetics: risk factors considered for predictive diagnostics and targeted preventive measures. EPMA J (2010) 0.86
Circulatory estrogen level protects against breast cancer in obese women. Recent Pat Anticancer Drug Discov (2013) 0.86
Proteome of human subcutaneous adipose tissue stromal vascular fraction cells versus mature adipocytes based on DIGE. J Proteome Res (2011) 0.85
Correlation analysis of two-dimensional gel electrophoretic protein patterns and biological variables. BMC Bioinformatics (2006) 0.85
Inhibitory effects of calcitriol on the growth of MCF-7 breast cancer xenografts in nude mice: selective modulation of aromatase expression in vivo. Horm Cancer (2011) 0.84
Thyroid hormone enhanced human hepatoma cell motility involves brain-specific serine protease 4 activation via ERK signaling. Mol Cancer (2014) 0.83
Clinical analysis of selected complement-derived molecules in human adipose tissue. J Transl Med (2013) 0.83
Characterization of breast cancer interstitial fluids by TmT labeling, LTQ-Orbitrap Velos mass spectrometry, and pathway analysis. J Proteome Res (2012) 0.81
Proteomic profiling of the tumor microenvironment: recent insights and the search for biomarkers. Genome Med (2014) 0.81
Adipose proteome analysis: focus on mediators of insulin resistance. Expert Rev Proteomics (2008) 0.81
Human adipocytes stimulate invasion of breast cancer MCF-7 cells by secreting IGFBP-2. PLoS One (2015) 0.81
Cell density is a critical determinant of aromatase expression in adipose stromal cells. J Steroid Biochem Mol Biol (2009) 0.80
An integrated approach based on multiplexed protein array and iTRAQ labeling for in-depth identification of pathways associated to IVF outcome. PLoS One (2013) 0.78
An Attempt to Evaluate Selected Aspects of "Bone-Fat Axis" Function in Healthy Individuals and Patients With Pancreatic Cancer. Medicine (Baltimore) (2015) 0.76
Acupuncture activates signal transduction pathways related to brain-tissue restoration after ischemic injury. Neural Regen Res (2012) 0.75
The Angiogenic Secretome in VEGF overexpressing Breast Cancer Xenografts. Sci Rep (2016) 0.75
Protein Array-based Approaches for Biomarker Discovery in Cancer. Genomics Proteomics Bioinformatics (2017) 0.75
Expression of NGF, BDNF and their high-affinity receptors in ovine mammary glands during development and lactation. Histochem Cell Biol (2015) 0.75
Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. J Cell Sci (2002) 4.25
Human Proteinpedia enables sharing of human protein data. Nat Biotechnol (2008) 4.21
Evidence for a stem cell hierarchy in the adult human breast. J Cell Biol (2007) 3.76
Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ (2005) 3.21
HERC2 coordinates ubiquitin-dependent assembly of DNA repair factors on damaged chromosomes. Nat Cell Biol (2009) 2.37
Population-based study of peritumoral lymphovascular invasion and outcome among patients with operable breast cancer. J Natl Cancer Inst (2009) 2.28
Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stroma. Am J Pathol (2003) 2.06
Improving the reproducibility of diagnosing micrometastases and isolated tumor cells. Cancer (2005) 1.91
Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery. Mol Cell Proteomics (2004) 1.57
IKAP localizes to membrane ruffles with filamin A and regulates actin cytoskeleton organization and cell migration. J Cell Sci (2008) 1.56
Expression of S100A4 by a variety of cell types present in the tumor microenvironment of human breast cancer. Int J Cancer (2007) 1.53
Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol. Acta Oncol (2008) 1.47
Human Xip1 (C2orf13) is a novel regulator of cellular responses to DNA strand breaks. J Biol Chem (2007) 1.38
Smoking is a risk factor for recurrence of groin hernia. World J Surg (2002) 1.25
Stromal cells associated with early invasive foci in human mammary ductal carcinoma in situ coexpress urokinase and urokinase receptor. Int J Cancer (2007) 1.24
A role for ADAM12 in breast tumor progression and stromal cell apoptosis. Cancer Res (2005) 1.24
Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity. Proc Natl Acad Sci U S A (2012) 1.21
Immediate and delayed effects of E-cadherin inhibition on gene regulation and cell motility in human epidermoid carcinoma cells. Mol Cell Biol (2005) 1.15
Urokinase receptor-associated protein (uPARAP) is expressed in connection with malignant as well as benign lesions of the human breast and occurs in specific populations of stromal cells. Int J Cancer (2002) 1.12
Performance of clinical mammography: a nationwide study from Denmark. Int J Cancer (2006) 1.11
Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast. Mol Oncol (2009) 1.07
Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group. Breast (2007) 1.06
Proteomics in translational cancer research: toward an integrated approach. Cancer Cell (2003) 1.05
The myofibroblast is the predominant plasminogen activator inhibitor-1-expressing cell type in human breast carcinomas. Am J Pathol (2003) 1.05
Human BLCAP transcript: new editing events in normal and cancerous tissues. Int J Cancer (2010) 1.04
Epithelial-stromal interaction 1 (EPSTI1) substitutes for peritumoral fibroblasts in the tumor microenvironment. Am J Pathol (2010) 1.01
bc10: A novel human bladder cancer-associated protein with a conserved genomic structure downregulated in invasive cancer. Int J Cancer (2002) 1.01
Expression of the tumor suppressor protein 14-3-3 sigma is down-regulated in invasive transitional cell carcinomas of the urinary bladder undergoing epithelial-to-mesenchymal transition. Mol Cell Proteomics (2004) 1.00
Loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) is associated with progression of human urothelial carcinomas. Mol Cell Proteomics (2005) 1.00
Molecular characterization of apocrine carcinoma of the breast: validation of an apocrine protein signature in a well-defined cohort. Mol Oncol (2009) 0.99
Bladder cancer-associated protein, a potential prognostic biomarker in human bladder cancer. Mol Cell Proteomics (2009) 0.98
Omics-based profiling of carcinoma of the breast and matched regional lymph node metastasis. Proteomics (2008) 0.95
Phosphoprotein Keratin 23 accumulates in MSS but not MSI colon cancers in vivo and impacts viability and proliferation in vitro. Mol Oncol (2007) 0.94
Plasma and serum levels of tissue inhibitor of metalloproteinases-1 are associated with prognosis in node-negative breast cancer: a prospective study. Mol Cell Proteomics (2007) 0.93
Proteomic profiling of mammary carcinomas identifies C7orf24, a gamma-glutamyl cyclotransferase, as a potential cancer biomarker. J Proteome Res (2010) 0.93
Interactions of ion transporters and channels with cancer cell metabolism and the tumour microenvironment. Philos Trans R Soc Lond B Biol Sci (2014) 0.92
Contribution of Na+,HCO3(-)-cotransport to cellular pH control in human breast cancer: a role for the breast cancer susceptibility locus NBCn1 (SLC4A7). Int J Cancer (2012) 0.92
A model for determining the effect of mammography service screening. Acta Oncol (2005) 0.92
Tumor interstitial fluid - a treasure trove of cancer biomarkers. Biochim Biophys Acta (2013) 0.91
Proteomic profiling of triple-negative breast carcinomas in combination with a three-tier orthogonal technology approach identifies Mage-A4 as potential therapeutic target in estrogen receptor negative breast cancer. Mol Cell Proteomics (2012) 0.91
Towards discovery-driven translational research in breast cancer. FEBS J (2005) 0.90
Sensitive detection of lysosomal membrane permeabilization by lysosomal galectin puncta assay. Autophagy (2015) 0.90
Molecular pathology of breast apocrine carcinomas: a protein expression signature specific for benign apocrine metaplasia. FEBS Lett (2006) 0.89
Breast cancer incidence, case-fatality and breast cancer mortality in Danish women using hormone replacement therapy--a prospective observational study. Int J Epidemiol (2005) 0.89
A single lysis solution for the analysis of tissue samples by different proteomic technologies. Mol Oncol (2008) 0.88
Organochlorines, p53 mutations in relation to breast cancer risk and survival. A Danish cohort-nested case-controls study. Breast Cancer Res Treat (2002) 0.88
A comparison of reproductive risk factors for CIS lesions and invasive breast cancer. Int J Cancer (2004) 0.88
15-prostaglandin dehydrogenase expression alone or in combination with ACSM1 defines a subgroup of the apocrine molecular subtype of breast carcinoma. Mol Cell Proteomics (2008) 0.88
Matrix metalloproteinase 13 is induced in fibroblasts in polyomavirus middle T antigen-driven mammary carcinoma without influencing tumor progression. PLoS One (2008) 0.87
TIMP-1 increases expression and phosphorylation of proteins associated with drug resistance in breast cancer cells. J Proteome Res (2013) 0.86
Human FK506 binding protein 65 is associated with colorectal cancer. Mol Cell Proteomics (2005) 0.85
Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia. Mol Oncol (2007) 0.84
Integrating proteomic and functional genomic technologies in discovery-driven translational breast cancer research. Mol Cell Proteomics (2003) 0.84
Sentinel node biopsy in breast cancer: five years experience from Denmark. Acta Oncol (2008) 0.84
A combined proteome and ultrastructural localization analysis of 14-3-3 proteins in transformed human amnion (AMA) cells: definition of a framework to study isoform-specific differences. Mol Cell Proteomics (2008) 0.84